Corporate ActionJul 21, 2026, 04:22 PM
VolitionRx Reduces Authorized Shares to 150M
AI Summary
VolitionRx Limited filed an amendment to its Certificate of Incorporation to reduce the number of authorized shares of common stock from 325,000,000 to 150,000,000. This amendment was approved by stockholders at the 2026 annual meeting held on July 17, 2026. During the meeting, stockholders also elected seven directors, ratified the independent auditor, approved executive compensation, and approved the 2026 Stock Incentive Plan.
Key Highlights
- Authorized common stock reduced from 325,000,000 to 150,000,000 shares.
- Stockholders approved the reduction in authorized shares with 4,011,189 votes for.
- Seven directors were elected to serve until the next annual meeting.
- Sadler, Gibb & Associates, LLC ratified as independent auditor for 2026.
- Stockholders approved the 2026 Stock Incentive Plan.
- Stockholders approved executive officer compensation in a non-binding advisory vote.
Price Impact
More from VNRX